RL
Therapeutic Areas
Aplagon Pipeline
| Drug | Indication | Phase |
|---|---|---|
| APAC | Peripheral Arterial Occlusive Disease / Chronic Limb Threatening Ischemia | Phase 2a |
| Drug | Indication | Phase |
|---|---|---|
| APAC | Peripheral Arterial Occlusive Disease / Chronic Limb Threatening Ischemia | Phase 2a |